• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE - IRELAND ACUVUE® OASYS®; LENSES, SOFT CONTACT, EXTENDED WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE - IRELAND ACUVUE® OASYS®; LENSES, SOFT CONTACT, EXTENDED WEAR Back to Search Results
Catalog Number PH
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Conjunctivitis (1784); Foreign Body Sensation in Eye (1869); Red Eye(s) (2038); Blurred Vision (2137)
Event Date 03/15/2023
Event Type  Injury  
Manufacturer Narrative
Suspect product discarded.
 
Event Description
On (b)(6) 2023, a patient (pt) in brazil experienced blurry vision, yellow secretions, and burning sensation in both eyes (ou) on (b)(6) 2023 after a day of wearing acuvue® oasys® brand contact lenses (cls).The pt¿s eyes were irritated, red, ¿with yellow secretion¿ and blurry vision for 3 days upon cl removal.The pt continues to experience the same symptoms.The pt had not used any medication and was waiting to be seen by an eye care professional (ecp).The pt is a 1st time wearer and was not trial fit with the cls.The pt reported daily cls wear with a 1-2 month replacement schedule, and cleans the cls with biosoak solution.The pt is wearing glasses now and has not worn cls since the issue began.On (b)(6) 2023, the pt provided additional information via email.After two days of wearing the cls, removing at night, the pt woke up with burning sensation, red eyes, with ¿a lot of yellowish secretion and fog.¿ the pt visited an ecp and was diagnosed with bacterial conjunctivitis.The pt provided a copy of the prescription and ecp note via email.: prescription dated (b)(6) 2023: facoba eye drops use ou every 8 hours for 7 days -ecp note dated (b)(6) 2023: ¿pt with bacteria conjunctivitis ou.Begin treatment with eye drops.¿ image of red eye.On (b)(6) 2023, the pt provided additional information.The pt is currently using medication as prescribed and reported both eyes were better after 2 days of medication use.The pt reported the symptoms resolved after 3 days of using the medication.The pt will return to the ecp for a routine visit (not yet scheduled) and was cleared to resume cl wear after 7 days of treatment.No additional medical information has been received.No additional medical information is expected.This event was determined to be a serious adverse event on (b)(6), 2023 when the pt¿s diagnosis of bacterial conjunctivitis was provided.A lot history review was performed and revealed the following: the batch records did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot number l005k7w was produced under normal conditions.This report is for the pt's os event.The report for the pt's od event will be submitted in a separate report.The suspect os cls was discarded.No additional evaluation can be performed.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUVUE® OASYS®
Type of Device
LENSES, SOFT CONTACT, EXTENDED WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE - IRELAND
1 technological park plassey
limerick LK130 01
EI  LK13001
Manufacturer Contact
helene aguilar
7500 centurion parkway
jacksonville, FL 32256
9047429918
MDR Report Key16677721
MDR Text Key312651331
Report Number1057985-2023-00028
Device Sequence Number1
Product Code LPM
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P040045
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/04/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberPH
Device Lot NumberL005K7W
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received03/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient SexMale
-
-